Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Deep 3D Convolutional Encoder Networks with Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
Interpretation and visualization of non-linear data fusion in kernel space: study on metabolomic characterization of progression of multiple sclerosis.
Recommendations for diagnosis and management of multiple sclerosis.
Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.
Validity and reliability of VO2-max measurements in persons with multiple sclerosis.
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
Physiotherapy as an immunoactive therapy? A pilot study.
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
Fampridine – Benefit assessment according to § 35a Social Code Book V
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.
Santhera Receives European Marketing Authorization for Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Role of statins in the treatment of multiple sclerosis.
Biotechnology industry leader Centocor Ortho Biotech is now Janssen Biotech, Inc., part of the Janssen pharmaceutical companies
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
miRNA in multiple sclerosis: search for novel biomarkers.
TAPP1 inhibits the differentiation of oligodendrocyte precursor cells via suppressing the Mek/Erk pathway.
Video game training enhances cognitive control in older adults.
Association of multiple sclerosis susceptibility variants and early attack location in the CNS.

Pages